5- (2-Fluorophenyl) -1H-Pyrrole-3-Carbaldehyde CAS 881674-56-2 Vonoprazan Fumarate Intermediate Ọcha ≥99.0%

Nkọwa dị mkpirikpi:

Aha: 5- (2-Fluorophenyl) -1H-Pyrrole-3-Carbaldehyde

CAS: 881674-56-2

ịdị ọcha: ≥99.0%

Ọdịdị: Yellow ruo Brown Powder

Ọkara nke Vonoprazan Fumarate (CAS: 1260141-27-2)

Ogo dị elu, nrụpụta azụmahịa

Inquiry: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Njirimara kemịkalụ:

Aha Chemical 5- (2-Fluorophenyl) -1H-Pyrrole-3-Carbaldehyde
Ụdị okwu Vonoprazan Fumarate (TAK-438) Nke etiti 3
Nọmba CAS 881674-56-2
Nọmba CAT RF-PI330
Ọnọdụ Ahịa N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi C11H8FNO
Ibu molekụla 189.19
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Yellow ruo Brown ntụ ntụ
Ebe Na-agbaze 122.0 ~ 131.0 ℃
njirimara: RT(HPLC) Dabaa n'ụkpụrụ ntụaka
Ọnwụ na ihicha ≤0.50%
Ihe fọdụrụ na mgbanye ≤0.50%
Ihe ndị emetụtara
Ịdị ọcha ≥99.0%
Ọdịghị ọcha ọ bụla ≤0.50%
Mgbakọta adịghị ọcha ≤1.0%
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji Ọkara nke Vonoprazan Fumarate (TAK-438) (CAS 881681-01-2)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe pụọ na ọkụ, mmiri mmiri na ọrịa nje.

Uru:

1

Ajụjụ:

Ngwa:

5- (2-Fluorophenyl) -1H-Pyrrole-3-Carbaldehyde (CAS 881674-56-2) na-arụ ọrụ dị ka reagent na nkwadebe sịntetik nke ihe ndị na-emepụta pyrrole ọhụrụ dị ka potassium-competitive acid blocker (P-CAB).5- (2-Fluorophenyl) pyrrole-3-Carboxaldehyde bụ etiti nke Vonoprazan Fumarate (CAS 1260141-27-2).Vonoprazan fumarate (Takecab®), nke Takeda na Otsuka chọtara ma mepụta, PMDA nke Japan kwadoro na Disemba 2014, a na-egosikwa ya maka ọgwụgwọ ọnya afọ, ọnya duodenal na reflux esophagitis.Vonoprazan fumarate nwere usoro ihe omume nke a na-akpọ potassium-competitive acid blockers, bụ nke na-egbochi njikọ nke ion potassium na H +, K+-ATPase (nke a makwaara dị ka mgbapụta proton) na njedebe ikpeazụ nke secretion acid gastric na cell parietal gastric.Vonoprazan anaghị egbochi ọrụ Na +, K+-ATPase ọbụna na mkpokọta 500 ugboro dị elu karịa nke ụkpụrụ IC50 ha megide gastric H +, K+-ATPase ọrụ.Ọzọkwa, ọgwụ ahụ adịghị emetụta steeti secretory gastric, n'adịghị ka PPI.

Dee ozi gị ebe a ziga anyị ya